Filter by

Keywords

Congress

Year

abstract book

Access here all Abstracts accepted for oral and e-poster presentation at PCR congresses. You can browse by theme, topic or if you know what you are looking for, by author, title using the free search

Tokyo20A-OP002
Impact of aortic valve area for hyper-coagulation status after TAVI
KATAYAMA T. (1), YOKOYAMA N. (1), TAKAHASHI S. (1), NAGURA F. (1), ITO M. (1), NOMURA T. (1), HIOKI H. (1), KATAOKA A. (1), WATANABE Y. (1), KOZUMA K. (1)
(1) Teikyo University, Tokyo JAPAN

+

Tokyo20A-OP003
Zero contrast TAVI in patients with severe renal dysfunction
YUKIMITSU N. (1), YUSUKE W. (1), HIROFUMI H. (1), AKIHISA K. (1), KEN K. (1)
(1) Teikyo University, Tokyo JAPAN

+

Tokyo20A-OP004
Comparison of the results of TAVI in patients with bi- and tricuspid aortic valve with selection of valve size based on annular sizing
CHODóR P. (1), WILCZEK K. (1), CHODóR-ROZWADOWSKA K. (2), PRZYBYLSKI R. (1), GLOWACKI J. (1), WLOCH (1), GASIOR M. (1), ZEMBALA M. (1), KALARUS Z. (1)
(1) Silesian Center for Heart Diseases, Zabrze POLAND
(2) Students Scientific Society, Medical University of Silesia, Katowice POLAND

+

Tokyo20A-OP005
Novel dedicated paravalvular leak occluder (VALE project)
WOJAKOWSKI W. (1), SMOLKA G. (1), TENDERA M. (1), DUDEK D. (1), PLOWIECKI E. (2), PASLAWSKA U. (3), WOJCIECH Z. (4)
(1) Medical University of Silesia, Katowice POLAND
(2) Balton Sp. z o.o., Warsaw POLAND
(3) Wrocław University of Environmental and Life Sciences, Wrocław POLAND
(4) KCRI, Kraków POLAND

+

Tokyo20A-OP006
Transition from general anaesthesia to conscious sedation during TAVI, and its positive impact on the cathlab administrational workflow and nursing pre-, peri-, and post-procedural workload in a tertiary hospital in Cyprus
DRAKOMATHIOULAKIS M. (1), GATIDIS A. (1), EFTYCHIOU C. (1), LOUKAIDOU P. (1), NTAKA A. (1), AVRAAMIDES P. (1)
(1) Nicosia General Hospital, Strovolos CYPRUS

+

Tokyo20A-OP008
Impact of beta blockers on patients undergoing TAVR
SAITO T. (1), HASE H. (1), YOSHIJIMA N. (1), HAYASHIDA K. (1), TSURUTA H. (1), SHIMIZU H. (1), TAKAHASHI T. (1), ITO T. (1), YAMAZAKI M. (1), FUKUDA K. (1)
(1) Keio University, Tokyo JAPAN

+

Tokyo20A-OP009
Incidence and management of severe structural valve degeneration after TAVR: a single-centre experience
LEE Y. T. (1), YIN W. H. (1)
(1) Cheng Hsin General Hospital, Taipei City TAIWAN

+

Tokyo20A-OP010
Relationship between intra-operative haemodynamic parameters and delayed haemodynamic recovery after valve deployment in TAVR
KAMEYAMA A. (1), ITO H. (1), KAWAKAMI M. (2), UENO H. (1), FUKAHARA K. (1)
(1) University of Toyama, Toyama JAPAN
(2) Kanazawa University, Ishikawa JAPAN

+

Tokyo20A-OP011
3D printed silicone casted TAVI training simulator
RUDZINSKI P. N. (1), KöNIGSHOFER M. (1), MACH M. (1), RUSSO M. (1), WERNER P. (1), MOSCATO F. (1), EHRLICH M. (1), ANDREAS M. (1)
(1) Allgemeines Krankenhaus der Stadt Wien, Vienna AUSTRIA

+

Tokyo20A-OP012
Inflammatory reaction associated with leaflet thrombosis in the transcatheter aortic valve
SAKU K. (1), SAKU K. (2), TAKASEYA T. (2), TAHARA N. (2), SASAKI K. (2), OTSUKA H. (2), ITAYA N. (2), HONDA A. (2), SASAKI M. (2), UENO T. (2), TANAKA H. (2)
(1) ,
(2) Kurume University, Fukuoka JAPAN

+

Tokyo20A-OP013
Clinical and haemodynamic outcomes of patients who underwent transcatheter mitral valve-in-valve replacement: one-month results
RAO R. (1), SUBBAN V. (2), K D. (3), SATISH S. (3), DHARESHWAR J. (4), MEHROTRA S. (5), ABEDIN H. Z. (6), RAJASEKHAR V. (7), CHOPRA M. (8), MULLASARI S A. (2)
(1) Eternal Heart Care Centre, Rajasthan INDIA
(2) The Madras Medical Mission, Tamil Nadu INDIA
(3) Apollo Hospitals, Tamil Nadu INDIA
(4) Jupiter Hospital, Maharashtra INDIA
(5) Narayana Institute of Cardiac Sciences, Karnataka INDIA
(6) Masina Hospital, Maharashtra INDIA
(7) Yashoda Hospitals, Telangana INDIA
(8) Narayana Multispeciality Hospital, Gujarat INDIA

+

Tokyo20A-OP014
経カテーテル的大動脈弁留置術後の腎機能改善因子の検討
YOKOTA S. (1), YOKOTA S. (2), YAMANAKA F. (2), SHISHIDO K. (2), NOGUCHI K. (2), SAITO S. (2)
(1) ,
(2) Shonan Kamakura General Hospital, Kanagawa JAPAN

+

Tokyo20A-OP015
Predictive factors of no symptomatic improvement after TAVI
YOSHIJIMA N. (1), HAYASHIDA K. (1), KOBARI Y. (1), MYOJIN S. (1), RYUZAKI T. (1), SAITO T. (1), HASE H. (1), TSURUTA H. (1), TAKAHASHI T. (1), SHIMIZU H. (1)
(1) Keio University Hospital, Tokyo JAPAN

+

Tokyo20A-OP016
The efficacy of direct visualization of MANTA using ultrasound-navigated technique following large-bore arteriotomy
MORIYAMA N. (1), LAINE M. (1)
(1) Helsinki University Central Hospital, Helsinki FINLAND

+

Tokyo20A-OP017
Short- and long-term outcomes of patients with and without end-stage renal disease on dialysis undergoing TAVI: a meta-analysis
KUNO T. (1), TAKAGI H. (2), ANDO T. (3), UEYAMA H. (1), KODAIRA M. (4), NUMASAWA Y. (4), BRIASOULIS A. (5), HAYASHIDA K. (6)
(1) Mount Sinai Beth Israel, NY UNITED STATES
(2) Shizuoka Medical Center, Shizuoka JAPAN
(3) Columbia University, NY UNITED STATES
(4) Japanese Red Cross Ashikaga Hospital, Tochigi JAPAN
(5) University of Iowa Hospitals & Clinics, Iowa UNITED STATES
(6) Keio University Hospital, Tokyo JAPAN

+

Tokyo20A-OP018
Impact of immunosuppressive therapy on clinical outcomes of severe aortic stenosis treated with TAVI
KAIHARA T. (1), KAIHARA T. (1), KAIHARA T. (2), KUWATA S. (1), KOGA M. (1), WATANABE M. (1), OKUYAMA K. (1), KAMIJIMA R. (1), IZUMO M. (1), ISHIBASHI Y. (1), TANABE Y. (1), HIGUMA T. (1), AKASHI Y. (1)
(1) St. Marianna University School of Medicine, Kanagawa JAPAN
(2) ,

+

Tokyo20A-OP019
Importance of combined assessment of skeletal muscle mass and density by CT in predicting clinical outcomes after TAVR
TOKUDA T. (1), YAMAMOTO M. (2), OTSUKA T. (3), TADA N. (4), NAGANUMA T. (5), YAMANAKA F. (6), SHIRAI S. (7), MIZUTANI K. (8), TABATA M. (9), UENO H. (10), HIGASHIMORI A. (11), ARAKI M. (12), WATANABE Y. (13), HAYASHIDA K. (14)
(1) Nagoya heart center, Aichi JAPAN
(2) Toyohashi heart center, Aichi JAPAN
(3) Nippon Medical School Hospital, Tokyo JAPAN
(4) Sendai Kousei Hospital, Miyagi JAPAN
(5) New Tokyo Hospital, Chiba JAPAN
(6) Shonan Kamakura General Hospital, Kanagawa JAPAN
(7) Kokura Memorial Hospital, Fukuoka JAPAN
(8) Osaka City General Hospital, Osaka JAPAN
(9) Tokyo Bay Urayasu Ichikawa Medical Center, Chiba JAPAN
(10) toyama university hospital, Toyama JAPAN
(11) Kishiwada Tokushukai Hospital, Osaka JAPAN
(12) Saiseikai Yokohamashi Tobu Hospital, Kanagawa JAPAN
(13) Teikyo University, Tokyo JAPAN
(14) Keio University, Tokyo JAPAN

+

Tokyo20A-OP021
A combination of malnutrition and muscle weakness deteriorates clinical outcomes after TAVR
UCHIDA Y. (1), TAMENISHI A. (1), ICHIMIYA H. (1), WATANABE J. (1), KANASHIRO M. (1), ICHIMIYA S. (1)
(1) Yokkaichi Municipal Hospital, Mie JAPAN

+

Tokyo20A-OP023
Clinical sequelae and determinants of subclinical leaflet thrombosis following TAVI with 320-multislice CT at medium term follow-up
RASHID H. (1), MICHAIL M. (1), KHAV N. (1), IHDAYHID A. (1), TAN S. (1), CAMERON J. (1), NASIS A. (1), GOOLEY R. (1)
(1) Monash Medical Centre, VIC AUSTRALIA

+

Tokyo20A-OP024
Large bore vessel closure by MANTA - Avoiding post-closure vessel stenosis
BAUERNSCHMITT R. (1), GUZMAN J. (1), GRUNEBAUM J. P. (1), SODIAN R. (1)
(1) MediClin Heart Center Lahr / Baden, Lahr GERMANY

+

Tokyo20A-POS001
Haemolytic anaemia induced by MitraClip
YUKIO O. (1), YUKIO O. (2), OZAKI Y. (1), OZAKI Y. (2), YOSHIKI Y. (2), HASHIMOTO Y. (2), TAKATSU H. (2), TORIYA T. (2), NAGASAKA R. (2), OHOTA M. (2), MURAMATSU T. (2)
(1) ,
(2) Fujita Health University Hospital, Aichi JAPAN

+

Tokyo20A-POS003
Clinical outcomes and echocardiographic risk stratification in patients with moderate aortic stenosis and reduced left ventricular ejection fraction
ONISHI H. (1), IZUMO M. (2), NAGANUMA T. (1), MITOMO S. (1), AKASHI Y. (2), NAKAMURA S. (1)
(1) New Tokyo Hospital, Chiba JAPAN
(2) St. Marianna University School of Medicine Yokohama City Seibu Hospital, Kanagawa JAPAN

+

Tokyo20A-POS004
Thrombocytopenia after transfemoral TAVI
UN K. C. (1), WONG C. K. (1), LAM C. C. (1), CHAN T. L. (1), TSE H. F. (1)
(1) Queen Mary Hospital, Pok Fu Lam HONG KONG

+

Tokyo20A-POS005
Impact of persistent right ventricular dysfunction on outcomes in patients with concomitant tricuspid regurgitation undergoing TAVI
DE JONGH M. (1), TSURUTA H. (1), HASE H. (1), YOSHIJIMA N. (1), SAITO T. (1), MYOJIN S. (1), KOBARI Y. (1), RYUZAKI T. (1), ITABASHI Y. (1), HAYASHDA K. (1), FUKUDA K. (1)
(1) Keio University, Tokyo JAPAN

+

Tokyo20A-POS006
Transcatheter vs. surgical aortic valve replacement for treatment of bicuspid aortic valve stenosis
FUJITA B. (1), BOZKURT K. (1), SAAD M. (1), EMMEL E. (1), EITEL I. (1), ABOUD A. (1), LANGER H. (1), ENSMINGER S. (1), KURZ T. (1)
(1) Lübeck Uniklinik, Lübeck GERMANY

+

Tokyo20A-POS007
Safety and feasibility of rotational atherectomy in severe aortic stenosis
BHATIA K. (1), SRITHARAN H. (1), ALLAHWALA U. (1), WARD M. (1), BHINDI R. (1)
(1) Royal North Shore Hospital, NSW AUSTRALIA

+

Tokyo20A-POS008
TAVI with Evolut R vs. Sapien 3 in small aortic annulus: the OCEAN-TAVI registry
HASE H. (1), YOSHIJIMA N. (1), SAITO T. (1), KOBARI Y. (1), MYOUJIN S. (1), RYUZAKI T. (1), TAKAHASHI T. (1), ITABASHI Y. (1), TSURUTA H. (1), HAYASHIDA K. (1), SHIMIZU H. (1)
(1) Keio University, Tokyo JAPAN

+

Tokyo20A-POS010
TAVR with the new balloon-expandable SAPIEN 3 Ultra vs. SAPIEN 3 valve system
MORIYAMA N. (1), LAINE M. (1)
(1) Helsiki University Central Hospital, Helsinki FINLAND

+

Tokyo20A-POS012
Frailty assessment as predictors of outcomes for TAVI
KOH J. Q. S. (1), MOHAMED RAHIM N. B. (1), SNG E. L. (1), YAP J. (1), ZHONG L. (1), LIM S. T. (1), EWE S. H. (1), CHAO V. (1), HO K. W. (1)
(1) National Heart Centre Singapore, National Heart Centre Singapore SINGAPORE

+

Lond19A-OP001
30-day outcomes from a global early feasibility study to assess the safety and effectiveness of a novel transfemoral TAVR system for the treatment of patients with symptomatic severe aortic regurgitation
VAHL T. (1), LEON M. (1), BALDUS S. (2), THOURANI V. (3), TREEDE H. (4), MAKKAR R. (5), KODALI S. (1), VAN MIEGHEM N. (6), RUDOLPH T. (7), WALTHER T. (8)
(1) Columbia University, NY UNITED STATES
(2) Uniklinik Köln, Cologne GERMANY
(3) MedStar Washington Hospital Center, DC UNITED STATES
(4) UKB University of Bonn, Bonn GERMANY
(5) Cedars-Sinai Medical Center, CA UNITED STATES
(6) Erasmus Universiteit Rotterdam, Rotterdam NETHERLANDS
(7) HDZ NRW, Bad Oeynhausen GERMANY
(8) Universitätsklinikum Frankfurt, Frankfurt GERMANY

+

Lond19A-OP002
Propensity score matched analysis between TAVI and isolated surgical aortic valve implantation in young high-risk patients aged 75 years or less
MACH M. (1), SLAKOV U. (2), WALLMüLLER C. (3), KEIL C. (3), STRATIL P. (3), STROUHAL A. (3), ADLBRECHT C. (3), DELLE-KARTH G. (3), GRABENWöGER M. (2), SCHOBER A. (3)
(1) Medical University of Vienna, Department of Cardiac Surgery, Vienna AUSTRIA
(2) Hospital Hietzing, Department of Cardiothoracic and Vascular Surgery, Vienna AUSTRIA
(3) Hospital Hietzing, Department of Cardiology, Vienna AUSTRIA

+

Lond19A-OP004
A novel heart failure score predicts adverse outcome in patients undergoing TAVI
MACH M. (1), WINKLER B. (2), SCHOBER A. (3), STROUHAL A. (3), DELLE-KARTH G. (3), GRABENWöGER M. (2), ADLBRECHT C. (3)
(1) Medical University of Vienna, Department of Cardiac Surgery, Vienna AUSTRIA
(2) Hospital Hietzing, Department of Cardiothoracic and Vascular Surgery, Vienna AUSTRIA
(3) Hospital Hietzing, Department of Cardiology, Vienna AUSTRIA

+

Lond19A-OP005
The FIFA-trial: FItness-tracker assisted Frailty-Assessment before TAVI
MACH M. (1), WATZAL V. (2), WINKLER B. (2), STROUHAL A. (3), ADLBRECHT C. (3), DELLE-KARTH G. (3), GRABENWöGER M. (2)
(1) Medical University of Vienna, Department of Cardiac Surgery, Vienna AUSTRIA
(2) Hospital Hietzing, Department of Cardiothoracic and Vascular Surgery, Vienna AUSTRIA
(3) Hospital Hietzing, Department of Cardiology, Vienna AUSTRIA

+

Lond19A-OP006
Predictors of permanent pacemaker implantation after TAVI in patients with very large annuli with a self-expanding valve
JIMENEZ V. A. (1), JIMENEZ DIAZ V. A. (1), LOPEZ OTERO D. (2), CRUZ GONZALEZ I. (3), AMAT-SANTOS I. (4), RIVERO F. (5), GUTIERREZ IBAñEZ E. (6), MUñOZ GARCIA A. (7), VAQUERIZO B. (8), MORENO SAMOS J. C. (3), RODRIGUEZ-GABELLA T. (4), GONZALEZ SALDIVAR H. (6)
(1) Hospital Álvaro Cunqueiro, Vigo SPAIN
(2) Hospital Universitario de Santiago de Compostela, Santiago de Compostela SPAIN
(3) Hospital Clínico Universitario de Salamanca, Salamanca SPAIN
(4) Hospital Clínico Universitario de Valladolid, Valladolid SPAIN
(5) Hospital de La Princesa, Madrid SPAIN
(6) Gregorio Marañón Hospital, Madrid SPAIN
(7) Hospital Universitario Virgen de la Victoria, Málaga SPAIN
(8) Hospital del Mar, Barcelona SPAIN

+

Lond19A-OP007
Very early discharge after transfemoral TAVI in selected patients; is it safe?
CALABUIG A. (1), VICENS S. (1), MARTI G. (1), SERRA B. (1), OTAEGUI I. (1), DOMINGO E. (1), BELLERA N. (1), DIAZ M. (1), SUASNAVAR P. (1), GONZALEZ S. (1), GARCIA B. (1)
(1) Vall d'Hebron University Hospital, Barcelona SPAIN

+

Lond19A-OP008
The concept of futility in treating functional mitral regurgitation in real world
GAVAZZONI M. (1), ADAMO M. (2), ESTéVEZ LOUREIRO R. (3), POZZOLI A. (1), CURELLO S. (2), BENITO T. (3), PORTOLèS A. (4), MIZUKI M. (1), SCIANNA S. (1), ZUBER M. (1), TARAMASSO M. (1), MAISANO F. (1)
(1) Universitätsspital Zürich, Zürich SWITZERLAND
(2) Spedali Civili, Piazzale Spedali Civili, Brescia, Province of Brescia ITALY
(3) university hospital, León SPAIN
(4) Hospital Puerta De Hierro, Majadahonda SPAIN

+

Lond19A-OP009
Systematic cerebral protection during TAVI: a single-centre experience
PIVA T. (1), NICOLINI E. (1), MUCAJ A. (1), ALESSANDRO M. (1), MIRCO B. (1), ANDREA A. (1), MASSIMILIANO S. (1), ALESSANDRO A. (1), GABRIELE G. (1)
(1) Ospedali Riuniti, Province of Ancona ITALY

+

Lond19A-OP010
Clinical data, performance and safety of TAVI in very large annuli with a self-expandable valve
JIMENEZ V. A. (1), JIMENEZ V. (1), LOPEZ-OTERO D. (2), CRUZ-GONZALEZ I. (3), AMAT-SANTOS I. (4), RIVERO F. (5), GUTIERREZ IBAñEZ E. (6), MUñOZ GARCIA A. (7), VAQUERIZO B. (8), TRILLO NOUCHE R. (2), MORENO SAMOS J. C. (3), RODRIGUEZ-GABELLA T. (4)
(1) Álvaro Cunqueiro Hospital, Vigo SPAIN
(2) Hospital, Santiago de Compostela SPAIN
(3) Hospital Clínico Universitario de Salamanca, Salamanca SPAIN
(4) Hospital Clínico Universitario de Valladolid, Valladolid SPAIN
(5) Hospital de La Princesa, Madrid SPAIN
(6) Gregorio Marañón Hospital, Madrid SPAIN
(7) Hospital Universitario Virgen de la Victoria, Málaga SPAIN
(8) Hospital del Mar, Barcelona SPAIN

+

Lond19A-OP011
First mid-/long-term follow-up results in patients undergoing TAVR with the self-expandable Portico valve for severe aortic stenosis: a real-world prospective study
MAS-PEIRO S. (1), SEPPELT P. C. (1), DE ROSA R. (1), MURRAY M. I. (1), WALTHER T. (1), ZEIHER A. M. (1), FICHTLSCHERER S. (1), VASA-NICOTERA M. (1)
(1) University Hospital Frankfurt, Frankfurt am Main GERMANY

+

Lond19A-OP012
Long-term experience with mechanical aortic valve prostheses after one-third of a century
AREF T. (1), WIEDEMANN D. (1), ROSENHEK R. (1), HIESMAYR M. (1), KOCHER A. (1), ANDREAS M. (1)
(1) Medical University of Vienna, Vienna AUSTRIA

+

Lond19A-OP013
Assessment of right atrial deformation indices in patients with different scales of significant secondary tricuspid regurgitation
OKUTUCU S. (1), SIMSEK V. (1), AKSOY H. (1), BURSA N. (2), YETIS SAYIN B. (1), OTO A. (1)
(1) Memorial Ankara Hastanesi, Ankara TURKEY
(2) Hacettepe Üniversitesi Beytepe Kampüsü, Ankara TURKEY

+

Lond19A-OP014
A prospective multicentre study of the SAPIEN 3 Ultra system in intermediate-risk patients with severe aortic stenosis
PRENDERGAST B. (1), HORLICK E. (2), RODES-CABAU J. (3), MACCARTHY P. (4), VELIANOU J. (5), WOOD D. (6), HOVORKA T. (7), WEBB J. (8)
(1) Guy's and St Thomas' NHS Foundation Trust, London UNITED KINGDOM
(2) Toronto General Hospital, ON CANADA
(3) Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), QC CANADA
(4) King's College Hospital NHS Foundation Trust, London UNITED KINGDOM
(5) Hamilton Health Sciences, McMaster University, Hamilton, ON, Hamilton CANADA
(6) St. Paul's Hospital, University of British Columbia, Vancouver, BC, Vancouver CANADA
(7) Edwards Lifesciences, Prague, Prague CZECH REPUBLIC
(8) St. Paul's Hospital, University of British Columbia, Vancouver CANADA

+

Lond19A-OP015
Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: insights from the multicentre GRASP-IT registry
ADAMO M. (1), GRASSO C. (2), POPOLO RUBBIO A. (2), CAPODANNO D. (2), CRISTINA G. (3), FIORELLI F. (3), PETRONIO A. S. (3), BEDOGNI F. (4), CURELLO S. (1), TAMBURINO C. (2)
(1) Spedali Civili of Brescia , Brescia ITALY
(2) CAST Policlinico Vittorio Emanuele, Catania ITALY
(3) AUOP Piasana, Pisa ITALY
(4) IRCCS Policlinico San Donato, Milano ITALY

+

Lond19A-OP016
Neurological events from the Evolut low-risk study
TCHETCHE D. (1), POPMA J. (2), YAKUBOV S. (3), DEEB G. M. (4), GLEASON T. (5), KLEIMAN N. (6), WALTON A. (7), REARDON M. (6)
(1) Clinic Pasteur, Toulouse FRANCE
(2) Beth Israel Deaconess Medical Center (BIDMC), MA UNITED STATES
(3) Riverside Methodist Hospital, OH UNITED STATES
(4) University of Michigan, MI UNITED STATES
(5) University of Pittsburgh, PA UNITED STATES
(6) Methodist Debakey Heart and Vascular Center, TX UNITED STATES
(7) The Alfred Hospital, VIC AUSTRALIA

+

Lond19A-OP017
Valve-in-valve implantation using the ACURATE neo in degenerated aortic bioprostheses: an international multicentre analysis
TOGGWEILER S. (1), HOLZAMER A. (2), KIM W. K. (3), SATHANANTHAN J. (4), KELLER L. (5), BRINKERT M. (1), HILKER M. (2), NIETLISPACH F. (5), WEBB J. (4)
(1) Luzerner Kantonsspital, Lucerne SWITZERLAND
(2) Universitätsklinikum Regensburg, Regensburg GERMANY
(3) Bad Nauheimer Klinik, Bad Nauheim GERMANY
(4) St Pauls Hospital, BC CANADA
(5) Universitätsspital Zürich, Zürich SWITZERLAND

+

Lond19A-OP018
Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using the new European definition - A multicentre French study
SOKOLOFF A. (1), DURAND E. (2), URENA ALCAZAR M. (3), HIMBERT D. (3), IUNG B. (3), BLANCHARD D. (4), GILARD M. (5), CRIBER A. (2), LEFEVRE T. (6), ELTCHANINOFF H. (2)
(1) INSTITUT MUTUALISTE MONTSOURIS, PARIS FRANCE
(2) HOPITAL CHARLES NICOLLE CHU ROUEN, ROUEN FRANCE
(3) Bichat-Claude Bernard Hospital, Paris FRANCE
(4) CLINIQUE SAINT-GATIEN - TOURS, TOURS FRANCE
(5) CHRU BREST SITE HOPITAL MORVAN, BREST FRANCE
(6) Cardiovascular Institute Paris Sud (ICPS), Massy FRANCE

+

Lond19A-OP019
A set of pre-specified risk criteria facilitates appropriately timed discharge and sustained outcomes to one year after hospital discharge for patients having transfemoral TAVI based on the FAST TAVI trial
SPENCE M. (1), BAAN J. (2), MARTINELLI G. L. (3), MUIR D. F. (4), SAIA F. (5), BORTONE A. (6), DENSEM C. G. (7), VAN DER KLEY F. (8), VAN MOURIK M. S. (2), BRAMLAGE P. (9), BARBANTI M. (10)
(1) Royal Victoria Hospital, Belfast UNITED KINGDOM
(2) UMCA - Locatie AMC, Amsterdam NETHERLANDS
(3) Clinica San Gaudenzio, Province of Novara ITALY
(4) The James Cook University Hospital, Middlesbrough UNITED KINGDOM
(5) S Orsola Malpighi Pad 5, Metropolitan City of Bologna ITALY
(6) University of Bari Aldo Moro, Metropolitan City of Bari ITALY
(7) Papworth Trust, Cambridge UNITED KINGDOM
(8) Leiden University Medical Center (LUMC), Leiden NETHERLANDS
(9) Institute for Pharmacology and Preventive Medicine, Cloppenburg GERMANY
(10) Policlinico ?Vittorio Emanuele?, Province of Catania ITALY

+

Lond19A-OP021
Transcatheter treatment of bicuspid aortic valves with the Evolut platform: interim analysis from the BIVOLUT-X registry
TCHETCHE D. (1), DE BIASE C. (1), ZIVIELLO F. (2), HOVASSE T. (3), SONDERGAARD L. (4), TEIGER E. (5), TELES R. (6), DUMONTEIL N. (1), VAN MIEGHEM N. (2)
(1) CLINIQUE PASTEUR, TOULOUSE FRANCE
(2) Erasmus MC, Rotterdam NETHERLANDS
(3) HOPITAL PRIVE JACQUES CARTIER, MASSY FRANCE
(4) Rigshospitalet, Copenhagen Municipality DENMARK
(5) HU HENRI MONDOR SITE HENRI MONDOR APHP, CRETEIL FRANCE
(6) Santa Cruz Hospital, Lisbon PORTUGAL

+

Lond19A-OP022
Adoption of newer MDCT measurements can lower pacemaker rates after TAVR in a community hospital setting
CHRYSANT G. (1), SPARLING J. (1), BEAGLES J. (1), CLARK C. (1), ELKINS C. (1)
(1) INTEGRIS Baptist Medical Center, OK UNITED STATES

+

Lond19A-OP023
Clinical and echocardiographic impact of under and over expansion of SAPIEN 3 transcatheter heart valves to tailor to aortic annular sizes
ADUSUMALLI S. (1), LAU K. (1), ROPER D. (1), SAVAGE M. (1), RAFFEL C. (1), SCALIA G. M. (1), POON K. (1)
(1) The Prince Charles Hospital, QLD AUSTRALIA

+

Loading...